Crystal City Apothecary Llc is an authorized DME supplier for medicare equipments and products.
Crystal City Apothecary Llc is a Community/Retail Pharmacy in Waverly, New York. It is located at 443 Cayuta Ave, Waverly and it's customer support contact number is 607-565-2390. The authorized person of Crystal City Apothecary Llc is Donald Sassman, RPH who is Owner And Pic of the pharmacy and his contact number is 607-565-2390. Active license number of Crystal City Apothecary Llc is 027521 for Community/Retail Pharmacy in New York. Crystal City Apothecary Llc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance. Crystal City Apothecary Llc is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Crystal City Apothecary Llc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
Crystal City Apothecary Llc
Type:
Community/Retail Pharmacy
Location:
443 Cayuta Ave, Waverly, New York, 14892-1506
Phone:
607-565-2390
Fax:
607-565-2393
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
Donald Sassman
Credentials:
RPH
Position:
Owner And Pic
Contact Number:
607-565-2390
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1639111412
NPI Enumeration Date:
13 Jun, 2006
NPI Last Update On:
22 Dec, 2010
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Crystal City Apothecary Llc are as mentioned below.
Specialization
License Number
State
Status
Community/Retail Pharmacy
027521
New York
Primary
Pharmacy
Secondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
02708529
Medicaid
New York
3348629
Other
Ncpdp Provider Identification Number
Medicare Enrollment:
Crystal City Apothecary Llc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID:
Enrollment ID:
Org Name
Medicare Entity Type
6709097298
O20100930041477
Crystal City Apothecary Llc
DME SUPPLIER - PHARMACY
Products Available:
Crystal City Apothecary Llc has following products available for sale under medicare.
Products
Blood Glucose Monitors & Supplies: Non-mail Order
Canes & Crutches
Commodes, Urinals, & Bedpans
Enteral Equipment And/or Supplies
Enteral Nutrients
Infusion Pumps & Supplies: Insulin Infusion
Orthoses: Off-the-shelf
Ostomy Supplies
Surgical Dressings
Urological Supplies
Walkers
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
443 Cayuta Ave, Waverly, New York
Zip:
14892-1506
Phone Number:
607-565-2390
Fax Number:
607-565-2393
Patients can reach Crystal City Apothecary Llc at 443 Cayuta Ave, Waverly, New York or can call on customer care at 607-565-2390.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.